LYY5:F:F-Mullti Units France - Lyxor MSCI Europe (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 190.14

Change

+3.18 (+1.70)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+15.83 (+3.24%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.73 (+1.51%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.85 (+1.61%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.22 (+1.52%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.95 (+1.36%)

USD 45.80B
0ZC:F Zscaler Inc

+6.74 (+3.99%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.69%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing LYY5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.34% 81% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.34% 82% B 72% C
Trailing 12 Months  
Capital Gain 4.98% 74% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.98% 72% C 58% F
Trailing 5 Years  
Capital Gain 74.09% 75% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.09% 75% C 52% F
Average Annual (5 Year Horizon)  
Capital Gain 11.47% 75% C 68% D+
Dividend Return 11.47% 72% C 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.07% 61% D- 89% A-
Risk Adjusted Return 103.69% 92% A 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike